HRTX
Price
$1.31
Change
-$0.01 (-0.76%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
200.81M
61 days until earnings call
LGVN
Price
$0.79
Change
+$0.04 (+5.33%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
15.56M
Interact to see
Advertisement

HRTX vs LGVN

Header iconHRTX vs LGVN Comparison
Open Charts HRTX vs LGVNBanner chart's image
Heron Therapeutics
Price$1.31
Change-$0.01 (-0.76%)
Volume$8.02K
Capitalization200.81M
Longeveron
Price$0.79
Change+$0.04 (+5.33%)
Volume$5.28K
Capitalization15.56M
HRTX vs LGVN Comparison Chart in %
Loading...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HRTX vs. LGVN commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRTX is a Hold and LGVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (HRTX: $1.32 vs. LGVN: $0.75)
Brand notoriety: HRTX and LGVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRTX: 76% vs. LGVN: 61%
Market capitalization -- HRTX: $200.81M vs. LGVN: $15.56M
HRTX [@Biotechnology] is valued at $200.81M. LGVN’s [@Biotechnology] market capitalization is $15.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRTX’s FA Score shows that 0 FA rating(s) are green whileLGVN’s FA Score has 1 green FA rating(s).

  • HRTX’s FA Score: 0 green, 5 red.
  • LGVN’s FA Score: 1 green, 4 red.
According to our system of comparison, LGVN is a better buy in the long-term than HRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRTX’s TA Score shows that 5 TA indicator(s) are bullish while LGVN’s TA Score has 4 bullish TA indicator(s).

  • HRTX’s TA Score: 5 bullish, 4 bearish.
  • LGVN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, HRTX is a better buy in the short-term than LGVN.

Price Growth

HRTX (@Biotechnology) experienced а -5.04% price change this week, while LGVN (@Biotechnology) price change was -9.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.90%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

HRTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRTX($201M) has a higher market cap than LGVN($15.6M). HRTX YTD gains are higher at: -13.725 vs. LGVN (-56.757). HRTX has higher annual earnings (EBITDA): 7.54M vs. LGVN (-18.35M). HRTX has more cash in the bank: 40.6M vs. LGVN (10.3M). LGVN has less debt than HRTX: LGVN (1.14M) vs HRTX (177M). HRTX has higher revenues than LGVN: HRTX (150M) vs LGVN (2.07M).
HRTXLGVNHRTX / LGVN
Capitalization201M15.6M1,288%
EBITDA7.54M-18.35M-41%
Gain YTD-13.725-56.75724%
P/E RatioN/A3.17-
Revenue150M2.07M7,236%
Total Cash40.6M10.3M394%
Total Debt177M1.14M15,526%
FUNDAMENTALS RATINGS
HRTX: Fundamental Ratings
HRTX
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HRTXLGVN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
85%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTUMF0.04N/A
+6.49%
BTU METALS CORP.
MPZZF1.800.01
+0.56%
MPC Container Ships AS
CBUMY34.82N/A
N/A
China National Buildings Material
SCGY0.26N/A
N/A
Scientific Energy, Inc.
DIDIY6.25-0.02
-0.32%
DiDi Global Inc.

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with GSGTF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
-0.75%
GSGTF - HRTX
45%
Loosely correlated
N/A
AMRN - HRTX
44%
Loosely correlated
-0.07%
CYCN - HRTX
40%
Loosely correlated
-1.44%
AXON - HRTX
38%
Loosely correlated
+0.67%
ARRY - HRTX
36%
Loosely correlated
+5.09%
More

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with QURE. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
-8.31%
QURE - LGVN
37%
Loosely correlated
+2.01%
RXRX - LGVN
36%
Loosely correlated
-2.38%
SNGX - LGVN
36%
Loosely correlated
-1.30%
HRTX - LGVN
35%
Loosely correlated
-0.75%
PROK - LGVN
34%
Loosely correlated
-2.54%
More